In summary, our data indicated that RNF122 activated the JAK2/STAT3/c‐Myc axis to facilitate GBM cell proliferation and cell cycle and RNF122 activated JAK2/STAT3 signaling, which promoted c‐Myc protein expression and promoted GBM progression. Here, STAT3 is linked to glioblastoma.